Autosomal recessive hypophosphatemic rickets

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

4 events
Mar 2025ENERGY 2: Evaluation of the Efficacy and Safety of INZ-701 in Infants With ENPP1 Deficiency

Inozyme Pharma — PHASE3

TrialRECRUITING
Jul 2024PROPEL - A Prospective Observational Patient Registry to Evaluate ENPP1 and ABCC6 Deficiency

Inozyme Pharma

TrialRECRUITING
Nov 2023The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency

Inozyme Pharma — PHASE3

TrialACTIVE NOT RECRUITING
Jun 2023The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency

Inozyme Pharma — PHASE1

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Autosomal recessive hypophosphatemic rickets.
Check the disease page for updates →

Clinical Trial Landscape

3 active trials
2Phase 3
1Phase 1
3Total recruiting
Search clinical trials for Autosomal recessive hypophosphatemic rickets

Recent News & Research

No recent news articles indexed yet for Autosomal recessive hypophosphatemic rickets.
Search PubMed for Autosomal recessive hypophosphatemic rickets

Browse all Autosomal recessive hypophosphatemic rickets news →

Specialist Network

Top 4 by expertise

View all Autosomal recessive hypophosphatemic rickets specialists →

Quick Actions